Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 13, 2013 - Issue 2: Monoclonal Antibodies
Submit an article Journal homepage
361
Views
13
CrossRef citations to date
0
Altmetric
Drug Evaluations

Contemporary use of bevacizumab in ovarian cancer

Takahito M MiyakeDepartment of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1155 Herman Pressler, Unit 1362, Houston, TX 77030, USA
,
Anil K SoodDepartment of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1155 Herman Pressler, Unit 1362, Houston, TX 77030, USA;Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, [email protected];Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
&
Robert L ColemanDepartment of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1155 Herman Pressler, Unit 1362, Houston, TX 77030, USA;Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, [email protected]
Pages 283-294 | Published online: 29 Nov 2012

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ying-dong Cheng, Hua Yang, Guo-qing Chen & Zhi-cao Zhang. (2013) Molecularly targeted drugs for metastatic colorectal cancer. Drug Design, Development and Therapy 7, pages 1315-1322.
Read now

Articles from other publishers (12)

Guiqin Ye, Mengting Xu, Yuhan Shu, Xin Sun, Yuanyuan Mai, Yupeng Hong, Jianbin Zhang & Jingkui Tian. (2022) A Quassinoid Diterpenoid Eurycomanone from Eurycoma longifolia Jack Exerts Anti-Cancer Effect through Autophagy Inhibition. Molecules 27:14, pages 4398.
Crossref
Ramy M. Hanna, Rebecaa S. Ahdoot, Matthew S. Kim, Kenar D. Jhaveri, Kamyar Kalantar-Zadeh & Ira B. Kurtz. (2022) Intravitreal vascular endothelial growth factors hypertension, proteinuria, and renal injury: a concise review. Current Opinion in Nephrology & Hypertension 31:1, pages 47-56.
Crossref
Ramy M Hanna, Eduardo A Lopez, Huma Hasnain, Umut Selamet, James Wilson, Peter N Youssef, Nermeen Akladeous, Suphamai Bunnapradist & Michael B Gorin. (2019) Three patients with injection of intravitreal vascular endothelial growth factor inhibitors and subsequent exacerbation of chronic proteinuria and hypertension. Clinical Kidney Journal 12:1, pages 92-100.
Crossref
Dinesh Kumar Chellappan, Kun Hooi Leng, Lee Jia Jia, Nur Amirah Binti Abdul Aziz, Wong Chun Hoong, Yap Cheng Qian, Fam Yi Ling, Gwee Sing Wei, Tiong Ying, Jestin Chellian, Gaurav Gupta & Kamal Dua. (2018) The role of bevacizumab on tumour angiogenesis and in the management of gynaecological cancers: A review. Biomedicine & Pharmacotherapy 102, pages 1127-1144.
Crossref
Patrick M. Reeves, Mojgan A. Abbaslou, Farah R.W. Kools, Kritchai Vutipongsatorn, Xiaoyun Tong, Christina Gavegnano, Raymond F. Schinazi & Mark C. Poznansky. (2017) Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice. Oncotarget 8:55, pages 94040-94053.
Crossref
Tatsuya Miyake, Keiichi Kumasawa, Noriko Sato, Tsuyoshi Takiuchi, Hitomi Nakamura & Tadashi Kimura. (2016) Soluble VEGF receptor 1 (sFLT1) induces non-apoptotic death in ovarian and colorectal cancer cells. Scientific Reports 6:1.
Crossref
Ramy M. Hanna, Eduardo Lopez, James Wilson, Shrinath Barathan & Arthur H. Cohen. (2016) Minimal change disease onset observed after bevacizumab administration. Clinical Kidney Journal 9:2, pages 239-244.
Crossref
Lily Liu, Haijia Yu, Xin Huang, Hongzhi Tan, Song Li, Yan Luo, Li Zhang, Sumei Jiang, Huifeng Jia, Yao Xiong, Ruliang Zhang, Yi Huang, Charles C Chu & Wenzhi Tian. (2015) A novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activity. BMC Cancer 15:1.
Crossref
Fidia Mumtahana, Xinli Tiang, Teng Zhang & Baoxia Cui. (2014) The efficacy and safety of Oxaliplatin-Vinorelbine as a second-line chemotherapy combination in patients with platinum-resistant pretreated epithelial ovarian cancer: A retrospective study. International Journal of Cancer Therapy and Oncology 2:4, pages 020413.
Crossref
Alexia Buzzonetti, Marco Fossati, Valentina Catzola, Giovanni Scambia, Andrea Fattorossi & Alessandra Battaglia. (2014) Immunological response induced by abagovomab as a maintenance therapy in patients with epithelial ovarian cancer: relationship with survival?a substudy of the MIMOSA trial. Cancer Immunology, Immunotherapy 63:10, pages 1037-1045.
Crossref
F. Stephen Hodi, Donald Lawrence, Cecilia Lezcano, Xinqi Wu, Jun Zhou, Tetsuro Sasada, Wanyong Zeng, Anita Giobbie-Hurder, Michael B. Atkins, Nageatte Ibrahim, Philip Friedlander, Keith T. Flaherty, George F. Murphy, Scott Rodig, Elsa F. Velazquez, Martin C. MihmJrJr, Sara Russell, Pamela J. DiPiro, Jeffrey T. Yap, Nikhil Ramaiya, Annick D. Van den Abbeele, Maria Gargano & David McDermott. (2014) Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma. Cancer Immunology Research 2:7, pages 632-642.
Crossref
Koji Matsuo, Todd B. Sheridan, Seiji Mabuchi, Kiyoshi Yoshino, Kosei Hasegawa, Kimberley D. Studeman, Dwight D. Im, Neil B. Rosenshein, Lynda D. Roman & Anil K. Sood. (2014) Estrogen receptor expression and increased risk of lymphovascular space invasion in high-grade serous ovarian carcinoma. Gynecologic Oncology 133:3, pages 473-479.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.